<DOC>
	<DOCNO>NCT02589964</DOCNO>
	<brief_summary>The study evaluate effectiveness probiotic therapy reduce incidence antibiotic associate diarrhea ( AAD ) Clostridium difficile associate diarrhea ( CDAD ) pneumonia patient .</brief_summary>
	<brief_title>Probiotics Reduction Antibiotic Associated Diarrhea</brief_title>
	<detailed_description>The study include patient admit Good Samariatan Hospital place pneumonia order set . After obtain consent , subject randomize proboiotic placebo group . Subjects follow 21 day start study treatment determine critical outcome incidence antibiotic-associated diarrhea C-Diff . Other outcome include length stay , healthcare cost , death .</detailed_description>
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<criteria>Admitted Good Samaritan Hospital Placed pneumonia order set Age 18+ Patient inadequate coherency understand consent Active Diarrhea admission Noncontrolled intestinal disease Documented positive C. difficile infection within 3 month enrollment Antibiotic use hospital admission Immunosuppressive therapy Pregnancy Allergic ingredient Florajen3 Allergic ingredient placebo Immunocompromised state include : HIV low CD4 count Active malignancy receive chemotherapy Medications include longterm steroid ( &gt; 2 week ) , disease modify biologic agent Acquired immune deficiency Unable take oral medication Less 4 dos probiotic placebo Taking probiotic past 30 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>probiotic</keyword>
	<keyword>antibiotic associate diarrhea</keyword>
	<keyword>clostridium difficile</keyword>
</DOC>